About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Psoriasis Clinical Trials in Houston | 43 Studies

Clinical Trials PsoriasisHouston

Psoriasis Clinical Trials in Houston

Find 43 clinical trials for psoriasis near Houston, Texas. Connect with research centers in your area.

All Psoriasis trials nationwide All trials in Houston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 21-40 of 43 trials

CompletedA Study of the Safety and Effectiveness of Ustekinumab in Patients With Psoriatic ArthritisThe purpose of this study is to evaluate the effectiveness (improvement of signs and symptoms) and safety of ustekinumab in participants with active psoriatic arthritis.NCT01009086·Encinitas, California and 101 others

Psoriasis Trials in Other Cities

New York Los Angeles Chicago Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

Active not recruitingA Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic MedicinesPsoriatic arthritis (PsA) is a chronic inflammatory disease that affects the joints and skin in people who have psoriasis (PsO).NCT06671496·Mesa, Arizona and 119 others

CompletedA Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Placebo and an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque PsoriasisThis is a study to compare the efficacy of bimekizumab versus placebo and an active comparator in the treatment of subjects with moderate to severe chronic plaque psoriasis (PSO).NCT03370133·Phoenix, Arizona and 104 others

CompletedA Study of the Safety and Efficacy of Golimumab in Patients With Active Psoriatic ArthritisThe purpose of this study is to evaluate the safety and efficacy (improvement of signs and symptoms) of subcutaneous (under the skin) injections of golimumab for the treatment of…NCT00265096·Huntsville, Alabama and 50 others

CompletedCertolizumab Pegol in Subjects With Adult Onset Active and Progressive Psoriatic ArthritisPhase 3, multicenter, randomized, double-blind, parallel-group, placebo-controlled study to evaluate the efficacy and safety of Certolizumab Pegol (CZP) in subjects with adult…NCT01087788·Birmingham, Alabama and 91 others

TerminatedStudy of Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic ArthritisThe primary objective of this study is to evaluate the efficacy of brodalumab, compared to placebo, in subjects with psoriatic arthritis.NCT02029495·Huntsville, Alabama and 151 others

CompletedEfficacy at 24 Weeks and Long Term Safety, Tolerability and Efficacy up to 2 Years of Secukinumab (AIN457) in Patients With Active Psoriatic Arthritis (PsA)This study will assess the efficacy and safety of secukinumab in patients with active psoriatic arthritis who are intolerant to or have had an inadequate response to NSAIDs…NCT01392326·Anniston, Alabama and 109 others

Active not recruitingStudy to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)Researchers are looking for new ways to treat Psoriatic Arthritis (PsA).NCT07486960·Sun City, Arizona and 49 others

TerminatedOnercept in the Treatment and Re-Treatment of Subjects With Moderate to Severe Plaque PsoriasisThe is a double-blind, placebo-controlled, randomized, and multicenter study consisting of a first treatment (FT) period followed by either an observation (OB) period and a…NCT00090129·Little Rock, Arkansas and 39 others

CompletedSafety and Efficacy Study of Apremilast to Treat Psoriatic ArthritisThe purpose of this study is to determine whether apremilast is safe and effective for treating patients with psoriatic arthritis.NCT01925768·Birmingham, Alabama and 70 others

RecruitingTesting of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint InhibitorsThis study learn how easily patients can use an educational tool that will be created for patients with melanoma and pre-existing autoimmune diseases who receive or will receive…NCT04751396·Houston, Texas

Active not recruitingA Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Have a History of Inadequate Response to or Intolerance to at Least One Disease Modifying Anti-Rheumatic Drug (DMARD) TherapyThe purpose of this study is to compare the safety and efficacy of risankizumab versus placebo in participants with moderately to severely active psoriatic arthritis (PsA).NCT03675308·Anniston, Alabama and 255 others

CompletedEfficacy, Safety, and Tolerability Study of Apremilast to Treat Early Oligoarticular Psoriatic Arthritis.This clinical study will test the effects of a drug called apremilast in oligoarticular psoriatic arthritis with less than 5 years of disease duration.NCT03747939·Mesa, Arizona and 113 others

CompletedLight Treatment Effectiveness (LITE) StudyTo compare the effectiveness, safety (tolerability), and duration of treatment response at 12 weeks of home versus office-based narrowband ultraviolet B phototherapy for the…NCT03726489·Birmingham, Alabama and 37 others

RecruitingContinuation Study of Zasocitinib in Adults With Psoriatic ArthritisPsoriatic arthritis (PsA) is a long-term inflammatory disease that affects the joints and skin.NCT07286058·Tucson, Arizona and 77 others

CompletedA Study of Ixekizumab in Participants With Active Psoriatic ArthritisThis study will assess the safety and efficacy of ixekizumab (LY2439821) compared to placebo in participants with active psoriatic arthritis.NCT01695239·Birmingham, Alabama and 115 others

CompletedA Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Topical ESR-114 in Subjects With Plaque PsoriasisThis is a multicenter, double-blind, randomized, vehicle-controlled, parallel-group proof-of-concept study designed to assess the safety, tolerability, pharmacokinetics, and…NCT03630939·Santa Monica, California and 9 others

CompletedExtension Study up to 3 Years for Secukinumab in Psoriatic ArthritisThis study was designed as a 3-year extension to the phase III core study CAIN457F2306.NCT01892436·Anniston, Alabama and 93 others

CompletedEfficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis (PsA)The purpose of this study is to determine whether apremilast is safe and effective in the treatment of patients with psoriatic arthritis who have not been previously treated with…NCT01307423·Phoenix, Arizona and 117 others

CompletedPALACE 3: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic ArthritisThe purpose of this study is to determine whether apremilast is safe and effective in the treatment of patients with psoriatic arthritis and a qualifying psoriasis lesion.NCT01212770·Birmingham, Alabama and 90 others

PreviousPage 2 of 3Next

Other Conditions in Houston

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia